Controversies in Thyroidology: Spring 2020 Meeting of the American Thyroid Association®

Controversies in Thyroidology: Spring 2020 Meeting of the American Thyroid Association®
May 28-30, 2020
Westin New York at Times Square, 270 West 43rd Street
New York, New York 10036
USA

The optimal management of thyroid disorders, nodules, and cancer is becoming increasingly more controversial with the emergence of newer, less invasive technologies, enhanced molecular diagnostics and improved, more accurate quality of life tools. In order to achieve the best clinical outcomes, clinicians need to be aware of these rapidly evolving areas and strive to develop individualized diagnostic and therapeutic strategies. The goal of the ATA Spring Meeting is to provide participants with a comprehensive understanding of the controversies surrounding many of these strategies and provide the appropriate tools to make the best, individualized treatment plan.  Areas of focus will include management of patients with Graves’ disease, ordering the appropriate laboratory studies, managing hypothyroidism and thyroid hormone replacement strategies. The role for percutaneous management of thyroid nodules or recurrent thyroid cancer and application of new technologies will be debated. The utility of molecular diagnostics and characterization of tumors to allow for limited surgeries and active surveillance strategies versus the traditional recommendation of surgical management of thyroid cancer will be thoroughly discussed. Through a combination of lectures, panel discussions, meet the professor sessions and case-based presentations, we will examine the most important, controversial, management issues faced by clinicians across the full spectrum of thyroid disorders.

ABOUT THE ATA SPRING MEETING

The Westin New York at Times Square is the perfect location to explore Manhattan. Walking distance to Broadway theaters, infamous Times Square and signature New York shopping, the Westin is an ideal location for thyroid education, networking opportunities and so much more. We invite you to join us at our two-day, clinical meeting Controversies in Thyroidology: Spring 2020 Meeting of the ATA taking place May 28-30, 2020 at the Westin New York at Times Square in New York, NY. The ATA Spring Meeting is an educational program offered in the United States in the year of the International Thyroid Congress (ITC). As you may or may not know, the 16th ITC will take place on September 8-13, 2020 in Xi’an, China. In the year of the ITC, ATA foregoes an annual meeting stateside and collaborates with the three international thyroid societies for one joint meeting. All abstracts and basic research interests should be directed to the ITC as the ATA spring meeting is a clinical program. Available 16th ITC details may be found online at https://www.thyroid.org/16th-itc/.

ATA SPRING MEETING TARGET AUDIENCE 

With anticipated attendance of nearly 500 healthcare professionals, the ATA Spring Meeting will bring together top researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology and related areas. The ATA Spring Meeting is open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer.

ATA SPRING MEETING LEARNING OBJECTIVES

At the conclusion of the ATA Spring Meeting, learners should:

  • Become familiar with novel treatment strategies for thyroid nodules and cancer and how they compare to conventional surgical therapies
  • Know the different ultrasonographic scoring systems and the benefits and limitations of each method in the evaluation and management of thyroid nodules
  • Understand the role of surveillance in the evaluation and follow up of thyroid nodules and a subset of thyroid cancer
  • Learn about molecular testing and its role at different points in the evaluation and treatment of thyroid nodules and thyroid cancer
  • Become familiar with changing treatment paradigms for Grave’s disease and Grave’s ophthalmopathy
  • Know the appropriate labs used to test thyroid disorders, and be familiar with limitations of various tests